BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 12657903)

  • 1. Tetrodotoxin blocks the circadian effects of NMDA during the day but not at night.
    Gamble KL; Novak CM; Paul KN; Albers HE
    Neuroreport; 2003 Mar; 14(4):641-4. PubMed ID: 12657903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tetrodotoxin administration in the suprachiasmatic nucleus prevents NMDA-induced reductions in pineal melatonin without influencing Per1 and Per2 mRNA levels.
    Paul KN; Gamble KL; Fukuhara C; Novak CM; Tosini G; Albers HE
    Eur J Neurosci; 2004 May; 19(10):2808-14. PubMed ID: 15147314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GABA interacts with photic signaling in the suprachiasmatic nucleus to regulate circadian phase shifts.
    Mintz EM; Jasnow AM; Gillespie CF; Huhman KL; Albers HE
    Neuroscience; 2002; 109(4):773-8. PubMed ID: 11927159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of NMDA receptors in the suprachiasmatic nucleus produces light-like phase shifts of the circadian clock in vivo.
    Mintz EM; Marvel CL; Gillespie CF; Price KM; Albers HE
    J Neurosci; 1999 Jun; 19(12):5124-30. PubMed ID: 10366645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NMDA-evoked calcium transients and currents in the suprachiasmatic nucleus: gating by the circadian system.
    Colwell CS
    Eur J Neurosci; 2001 Apr; 13(7):1420-8. PubMed ID: 11298803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropeptide Y and N-methyl-D-aspartic acid interact within the suprachiasmatic nuclei to alter circadian phase.
    Gamble KL; Novak CM; Albers HE
    Neuroscience; 2004; 126(3):559-65. PubMed ID: 15183505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropeptide Y, GABA and circadian phase shifts to photic stimuli.
    Lall GS; Biello SM
    Neuroscience; 2003; 120(4):915-21. PubMed ID: 12927198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circadian phase alteration by GABA and light differs in diurnal and nocturnal rodents during the day.
    Novak CM; Albers HE
    Behav Neurosci; 2004 Jun; 118(3):498-504. PubMed ID: 15174927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tetrodotoxin blocks NPY-induced but not muscimol-induced phase advances of wheel-running activity in Syrian hamsters.
    Huhman KL; Marvel CL; Gillespie CF; Mintz EM; Albers HE
    Brain Res; 1997 Oct; 772(1-2):176-80. PubMed ID: 9406970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circadian control during the day and night: Role of neuropeptide Y Y5 receptors in the suprachiasmatic nucleus.
    Gamble KL; Ehlen JC; Albers HE
    Brain Res Bull; 2005 May; 65(6):513-9. PubMed ID: 15862923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tetrodotoxin resets the clock.
    Noguchi T; Watanabe K
    Eur J Neurosci; 2005 Jun; 21(12):3361-7. PubMed ID: 16026473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects of constant light on circadian clock resetting by photic and nonphotic stimuli in Syrian hamsters.
    Landry GJ; Mistlberger RE
    Brain Res; 2005 Oct; 1059(1):52-8. PubMed ID: 16169532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions of GABA A receptor activation and light on period mRNA expression in the suprachiasmatic nucleus.
    Ehlen JC; Novak CM; Karom MC; Gamble KL; Albers HE
    J Biol Rhythms; 2008 Feb; 23(1):16-25. PubMed ID: 18258754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of single cell circadian response to NMDA by diacylglycerol lipase inhibition reveals a role of endocannabinoids in light entrainment of the suprachiasmatic nucleus.
    Sládek M; Liška K; Houdek P; Sumová A
    Neuropharmacology; 2021 Mar; 185():108455. PubMed ID: 33444638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attenuation of circadian light induced phase advances and delays by neuropeptide Y and a neuropeptide Y Y1/Y5 receptor agonist.
    Lall GS; Biello SM
    Neuroscience; 2003; 119(2):611-8. PubMed ID: 12770573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Developmental and circadian changes in Ca2+ mobilization mediated by GABAA and NMDA receptors in the suprachiasmatic nucleus.
    Ikeda M; Yoshioka T; Allen CN
    Eur J Neurosci; 2003 Jan; 17(1):58-70. PubMed ID: 12534969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Triptans attenuate circadian responses to light.
    Basu P; Ie N; Wensel AL; Baskerville JD; Smith VM; Antle MC
    Eur J Neurosci; 2015 Oct; 42(7):2489-95. PubMed ID: 26228801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced NMDA receptor activity in retinal inputs to the rat suprachiasmatic nucleus during the subjective night.
    Pennartz CM; Hamstra R; Geurtsen AM
    J Physiol; 2001 Apr; 532(Pt 1):181-94. PubMed ID: 11283234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microinjection of NMDA into the SCN region mimics the phase shifting effect of light in hamsters.
    Mintz EM; Albers HE
    Brain Res; 1997 May; 758(1-2):245-9. PubMed ID: 9203556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TTX blocks baclofen-induced phase shifts of the mammalian circadian pacemaker in vitro.
    Bergeron HE; Danielson B; Biggs KR; Prosser RA
    Brain Res; 1999 Sep; 841(1-2):193-6. PubMed ID: 10547002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.